India’s second wave causing severe global Covid vaccine supply chain disruption
India manufactures many drugs for export to the US, Europe and other markets, so its...
Glenmark reports positive data of Favipiravir in Covid-19 PMS study
Interim results from 503 subjects showed two-third of participants achieved clinical cure on day seven.
Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
Serum Institute is the sixth company in India to sign an agreement with the RDIF...
Cipla to market Roche’s Covid-19 antibody cocktail in India
Cipla said that the first batch of Roche’s antibody cocktail, Casirivimab and Imdevimab, is now...
CytoDyn to seek regulatory approval for Covid-19 drug Vyrologix
CytoDyn is set to submit the Phase III CD12 trial results of Vyrologix as Covid-19...
Natco Pharma and Lilly sign licencing deal for baricitinib use in India
Natco Pharma signs licencing agreement with Eli Lilly for baricitinib to treat Covid-19 in India.
Dr Reddy’s starts launch of Sputnik V Covid-19 vaccine in India
Dr Reddy’s begins vaccination with Sputnik V in India on receiving regulatory approval from the...
Lilly’s partnership with Indian drugmakers will expand access to Covid-19 treatment
The pacts will increase the availability of baricitinib in India as it battles a catastrophic...
Algernon’s Ifenprodil lowers interleukin 6 in Phase IIb/III Covid-19 trial
In the Phase IIb/III Covid-19 trial, Algernon’s Ifenprodil statistical significantly lowers interleukin 6.
India authorises DRDO’s oxygen dependence-lowering drug for Covid-19
The Drugs Controller General of India (DCGI) has granted emergency authorisation to an anti-Covid-19 drug,...
